Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genoveffa Franchini

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Frontiers in Immunology|September 20, 2024
Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisitionMohammad Arif Rahman, Isabela Silva de Castro, Luca Schifanella, et al.
Journal of Virology|October 16, 2009
Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strainMaria E Moreno-Fernandez, Wildeman Zapata, Jason T Blackard, et al.
Molecular Aspects of Medicine|August 3, 2010
Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteinsNancy Van Prooyen, Vibeke Andresen, Heather Gold, et al.
Journal of Virology|December 12, 2001
Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251Liljana Stevceva, Brian Kelsall, Janos Nacsa, et al.
Journal of Virology|September 29, 2004
Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulatorIhab Younis, Lyne Khair, Miroslav Dundr, et al.
Molecular Aspects of Medicine|March 25, 2010
HTLV-1 p13, a small protein with a busy agendaMicol Silic-Benussi, Roberta Biasiotto, Vibeke Andresen, et al.
Journal of Virology|July 22, 2016
Relationship between Vaccine-Induced Antibody Capture of Infectious Virus and Infection Outcomes following Repeated Low-Dose Rectal Challenges with Simian Immunodeficiency Virus SIVmac251Johannes S Gach, David Venzon, Monica Vaccari, et al.
The Journal of Biological Chemistry|December 27, 2002
Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcriptionRobert Harrod, Janos Nacsa, Carine Van Lint, et al.
Virology|December 20, 2002
Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaquesZdenek Hel, Janos Nacsa, Wen-Po Tsai, et al.
Retrovirology|March 31, 2005
International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trialsEdward Murphy, Steven Jacobson, Genoveffa Franchini, et al.
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Frontiers in Immunology|September 20, 2024
Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisitionMohammad Arif Rahman, Isabela Silva de Castro, Luca Schifanella, et al.
Journal of Virology|October 16, 2009
Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strainMaria E Moreno-Fernandez, Wildeman Zapata, Jason T Blackard, et al.
Molecular Aspects of Medicine|August 3, 2010
Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteinsNancy Van Prooyen, Vibeke Andresen, Heather Gold, et al.
Journal of Virology|December 12, 2001
Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251Liljana Stevceva, Brian Kelsall, Janos Nacsa, et al.
Journal of Virology|September 29, 2004
Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulatorIhab Younis, Lyne Khair, Miroslav Dundr, et al.
Molecular Aspects of Medicine|March 25, 2010
HTLV-1 p13, a small protein with a busy agendaMicol Silic-Benussi, Roberta Biasiotto, Vibeke Andresen, et al.
Journal of Virology|July 22, 2016
Relationship between Vaccine-Induced Antibody Capture of Infectious Virus and Infection Outcomes following Repeated Low-Dose Rectal Challenges with Simian Immunodeficiency Virus SIVmac251Johannes S Gach, David Venzon, Monica Vaccari, et al.
The Journal of Biological Chemistry|December 27, 2002
Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcriptionRobert Harrod, Janos Nacsa, Carine Van Lint, et al.
Virology|December 20, 2002
Equivalent immunogenicity of the highly attenuated poxvirus-based ALVAC-SIV and NYVAC-SIV vaccine candidates in SIVmac251-infected macaquesZdenek Hel, Janos Nacsa, Wen-Po Tsai, et al.
Retrovirology|March 31, 2005
International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trialsEdward Murphy, Steven Jacobson, Genoveffa Franchini, et al.
Pageof 17